Nanomechanical Hallmarks of Helicobacter pylori Infection in Pediatric Patients

Piotr Deptuła1, Łukasz Suprewicz1, Tamara Daniluk1

  • 1Department of Medical Microbiology and Nanobiomedical Engineering, Medical University of Bialystok, PL-15222 Bialystok, Poland.

Insights

Helicobacter pylori infection softens stomach tissue, offering a potential new diagnostic marker. Gastric cells remodel their cytoskeleton in response, which may lead to cancer development over time.

Area of Science:

  • Biophysics
  • Cell Biology
  • Gastroenterology

Background:

  • The molecular mechanisms underlying gastric cancer development due to Helicobacter pylori infection remain incompletely understood.
  • Nanomechanical insights into H. pylori infection pathophysiology are crucial for developing novel prevention, treatment, and diagnostic strategies for associated conditions like gastric ulcers and cancer.

Purpose of the Study:

  • To investigate the nanomechanical properties of H. pylori-infected gastric tissues and cells.
  • To explore the cellular response to H. pylori exposure at a mechanical level.

Main Methods:

  • Utilized atomic force microscopy (AFM) to measure the elastic modulus (Young's modulus) of healthy and H. pylori-positive human stomach tissues.
  • Assessed the mechanical response of human gastric cells exposed to heat-treated H. pylori using AFM.
  • Employed rapid urease tests and immunohistopathological staining to confirm H. pylori presence in tissue samples.

Main Results:

  • Infected gastric tissues exhibit softer nanomechanical properties compared to uninfected tissues, suggesting H. pylori presence.
  • Gastric cells demonstrate mechanical property modulation, partly mediated by cytoskeleton remodeling, upon exposure to H. pylori products.

Conclusions:

  • Tissue nanomechanical properties could serve as potential biomarkers for H. pylori infection.
  • Cellular mechanical tuning in response to H. pylori may contribute to long-term cancer development through persistent tissue property fluctuations.
Abstract

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
277
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
681
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
834
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
378
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
734
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.2K